| Trial ID: | L1103 |
| Source ID: | NCT00865449
|
| Associated Drug: |
Spironolactone
|
| Title: |
Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: spironolactone|DRUG: Placebo
|
| Outcome Measures: |
Primary: Peritoneal fibrosis, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2008-07
|
| Completion Date: |
2012-03
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-25
|
| Locations: |
Instituto Nacional de Cardiologia Ignacio Chavez, Mexico, DF, 14080, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT00865449
|
